nodes	percent_of_prediction	percent_of_DWPC	metapath
Masoprocol—LTB4R—macula lutea—glaucoma	0.459	0.925	CbGeAlD
Masoprocol—IGF1R—Stabilization and expansion of the E-cadherin adherens junction—PLEKHA7—glaucoma	0.0416	0.0861	CbGpPWpGaD
Masoprocol—LTB4R—Eicosanoid ligand-binding receptors—PTGFR—glaucoma	0.04	0.0827	CbGpPWpGaD
Masoprocol—CYP2J2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.0169	0.0351	CbGpPWpGaD
Masoprocol—IGF1R—IGF1 pathway—NCK2—glaucoma	0.0148	0.0306	CbGpPWpGaD
Masoprocol—Dobutamine—CA5A—glaucoma	0.0142	0.71	CrCbGaD
Masoprocol—IGF1R—eye—glaucoma	0.0133	0.0267	CbGeAlD
Masoprocol—IGF1R—Integrins in angiogenesis—COL11A1—glaucoma	0.0131	0.0271	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—BECN1—glaucoma	0.0129	0.0267	CbGpPWpGaD
Masoprocol—IGF1R—connective tissue—glaucoma	0.0128	0.0258	CbGeAlD
Masoprocol—IGF1R—SHP2 signaling—NTF4—glaucoma	0.0128	0.0265	CbGpPWpGaD
Masoprocol—IGF1R—MicroRNAs in cardiomyocyte hypertrophy—MYLK—glaucoma	0.00707	0.0146	CbGpPWpGaD
Masoprocol—ALOX5—connective tissue—glaucoma	0.00684	0.0138	CbGeAlD
Masoprocol—IGF1R—IRS-related events triggered by IGF1R—RPTOR—glaucoma	0.0064	0.0132	CbGpPWpGaD
Masoprocol—IGF1R—IGF1R signaling cascade—RPTOR—glaucoma	0.00623	0.0129	CbGpPWpGaD
Masoprocol—IGF1R—Posttranslational regulation of adherens junction stability and dissassembly—NTRK2—glaucoma	0.00618	0.0128	CbGpPWpGaD
Masoprocol—LTB4R—G alpha (q) signalling events—OPN4—glaucoma	0.0059	0.0122	CbGpPWpGaD
Masoprocol—Dobutamine—CA2—glaucoma	0.00582	0.29	CrCbGaD
Masoprocol—LTB4R—Spinal Cord Injury—C1QB—glaucoma	0.00573	0.0119	CbGpPWpGaD
Masoprocol—IGF1R—MicroRNAs in cardiomyocyte hypertrophy—HDAC9—glaucoma	0.00552	0.0114	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—COL11A1—glaucoma	0.00541	0.0112	CbGpPWpGaD
Masoprocol—IGF1R—SHP2 signaling—NTRK2—glaucoma	0.00531	0.011	CbGpPWpGaD
Masoprocol—LTB4R—G alpha (q) signalling events—PTGFR—glaucoma	0.00531	0.011	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	0.00527	0.0109	CbGpPWpGaD
Masoprocol—IGF1R—Endochondral Ossification—TGFB2—glaucoma	0.00515	0.0107	CbGpPWpGaD
Masoprocol—LTB4R—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.00498	0.0103	CbGpPWpGaD
Masoprocol—IGF1R—IGF1 pathway—BAD—glaucoma	0.00492	0.0102	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	0.00475	0.00983	CbGpPWpGaD
Masoprocol—CYP19A1—connective tissue—glaucoma	0.00473	0.00951	CbGeAlD
Masoprocol—IGF1R—Posttranslational regulation of adherens junction stability and dissassembly—BDNF—glaucoma	0.00461	0.00955	CbGpPWpGaD
Masoprocol—LTB4R—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.00456	0.00944	CbGpPWpGaD
Masoprocol—IGF1R—SHP2 signaling—NTRK1—glaucoma	0.00433	0.00896	CbGpPWpGaD
Masoprocol—CYP2J2—Tryptophan metabolism—CYP1B1—glaucoma	0.00418	0.00866	CbGpPWpGaD
Masoprocol—LTB4R—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.0041	0.0085	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—CAV2—glaucoma	0.0041	0.00849	CbGpPWpGaD
Masoprocol—IGF1R—SHP2 signaling—BDNF—glaucoma	0.00396	0.00821	CbGpPWpGaD
Masoprocol—CYP2J2—Arachidonic acid metabolism—CYP1B1—glaucoma	0.00391	0.0081	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.0039	0.00809	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—MYLK—glaucoma	0.00368	0.00762	CbGpPWpGaD
Masoprocol—ALOX5—Selenium Micronutrient Network—TXN—glaucoma	0.00359	0.00744	CbGpPWpGaD
Masoprocol—IGF1R—SHP2 signaling—NGF—glaucoma	0.00352	0.00728	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.00352	0.00728	CbGpPWpGaD
Masoprocol—ALOX5—Arachidonic acid metabolism—CYP1B1—glaucoma	0.00349	0.00722	CbGpPWpGaD
Masoprocol—CYP2J2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.00338	0.007	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—CCND2—glaucoma	0.00337	0.00699	CbGpPWpGaD
Masoprocol—CYP19A1—Endogenous sterols—CYP1B1—glaucoma	0.00334	0.00692	CbGpPWpGaD
Masoprocol—CYP2J2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.00334	0.00691	CbGpPWpGaD
Masoprocol—IGF1R—Plasma membrane estrogen receptor signaling—MMP2—glaucoma	0.00329	0.0068	CbGpPWpGaD
Masoprocol—IGF1R—Plasma membrane estrogen receptor signaling—NOS3—glaucoma	0.00308	0.00637	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—NGFR—glaucoma	0.00304	0.00629	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—CDKN2B—glaucoma	0.00302	0.00626	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—OPN4—glaucoma	0.00297	0.00616	CbGpPWpGaD
Masoprocol—IGF1R—MicroRNAs in cardiomyocyte hypertrophy—EDN1—glaucoma	0.00285	0.00589	CbGpPWpGaD
Masoprocol—ALOX5—Eicosanoid Synthesis—PTGS2—glaucoma	0.00283	0.00585	CbGpPWpGaD
Masoprocol—IGF1R—Integrins in angiogenesis—FN1—glaucoma	0.00275	0.00569	CbGpPWpGaD
Masoprocol—CYP2J2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.00274	0.00568	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—PTGFR—glaucoma	0.00268	0.00554	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—BDNF—glaucoma	0.00264	0.00547	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—IL1A—glaucoma	0.00254	0.00525	CbGpPWpGaD
Masoprocol—IGF1R—Apoptosis—FAS—glaucoma	0.00252	0.00522	CbGpPWpGaD
Masoprocol—IGF1R—Plasma membrane estrogen receptor signaling—MMP9—glaucoma	0.00247	0.00511	CbGpPWpGaD
Masoprocol—CYP19A1—FSH signaling pathway—BDNF—glaucoma	0.00246	0.0051	CbGpPWpGaD
Masoprocol—CYP19A1—Ovarian Infertility Genes—CCND2—glaucoma	0.00241	0.005	CbGpPWpGaD
Masoprocol—IGF1R—Apoptosis—BCL2L1—glaucoma	0.00238	0.00493	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—IL1A—glaucoma	0.00237	0.0049	CbGpPWpGaD
Masoprocol—IGF1R—SHP2 signaling—NOS3—glaucoma	0.00233	0.00483	CbGpPWpGaD
Masoprocol—ALOX5—Selenium Micronutrient Network—ABCA1—glaucoma	0.00222	0.00459	CbGpPWpGaD
Masoprocol—IGF1R—Apoptosis—BAD—glaucoma	0.00216	0.00447	CbGpPWpGaD
Masoprocol—ALOX5—Selenium Micronutrient Network—SOD1—glaucoma	0.00198	0.00409	CbGpPWpGaD
Masoprocol—CYP19A1—Tryptophan metabolism—CYP1B1—glaucoma	0.00192	0.00398	CbGpPWpGaD
Masoprocol—IGF1R—Integrins in angiogenesis—CDKN1B—glaucoma	0.00189	0.00392	CbGpPWpGaD
Masoprocol—CYP2J2—Biological oxidations—GSTT1—glaucoma	0.00183	0.00378	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—FN1—glaucoma	0.00183	0.00378	CbGpPWpGaD
Masoprocol—IGF1R—TSH signaling pathway—CDKN1B—glaucoma	0.00182	0.00377	CbGpPWpGaD
Masoprocol—LTB4R—G alpha (q) signalling events—EDN1—glaucoma	0.00176	0.00365	CbGpPWpGaD
Masoprocol—CYP2J2—Arachidonic acid metabolism—PTGS2—glaucoma	0.00176	0.00365	CbGpPWpGaD
Masoprocol—IGF1R—Endochondral Ossification—MMP9—glaucoma	0.00173	0.00358	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—CDKN2A—glaucoma	0.00173	0.00358	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—CCND2—glaucoma	0.00172	0.00357	CbGpPWpGaD
Masoprocol—IGF1R—Apoptosis—CDKN2A—glaucoma	0.0017	0.00351	CbGpPWpGaD
Masoprocol—IGF1R—SHP2 signaling—VEGFA—glaucoma	0.00168	0.00348	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—OPN4—glaucoma	0.00168	0.00348	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	0.00158	0.00327	CbGpPWpGaD
Masoprocol—IGF1R—Integrins in angiogenesis—VEGFA—glaucoma	0.00157	0.00326	CbGpPWpGaD
Masoprocol—ALOX5—Arachidonic acid metabolism—PTGS2—glaucoma	0.00157	0.00325	CbGpPWpGaD
Masoprocol—ALOX5—Selenium Micronutrient Network—MTHFR—glaucoma	0.00157	0.00325	CbGpPWpGaD
Masoprocol—IGF1R—Endochondral Ossification—VEGFA—glaucoma	0.00155	0.00322	CbGpPWpGaD
Masoprocol—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.00155	0.00321	CbGpPWpGaD
Masoprocol—CYP19A1—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.00153	0.00317	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—CDKN1B—glaucoma	0.00153	0.00317	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—OPN4—glaucoma	0.00153	0.00316	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—PTGFR—glaucoma	0.00151	0.00313	CbGpPWpGaD
Masoprocol—CYP2J2—Biological oxidations—CYP1B1—glaucoma	0.00146	0.00302	CbGpPWpGaD
Masoprocol—CYP2J2—Metapathway biotransformation—CYP1B1—glaucoma	0.00144	0.00297	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—PTGS2—glaucoma	0.00142	0.00294	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—CDKN2A—glaucoma	0.00142	0.00294	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—PTGFR—glaucoma	0.00137	0.00284	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.00136	0.00282	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—SMO—glaucoma	0.00135	0.0028	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—CDKN1B—glaucoma	0.00135	0.00279	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—LRP12—glaucoma	0.0013	0.00269	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CA5A—glaucoma	0.00128	0.00265	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—NARFL—glaucoma	0.00128	0.00265	CbGpPWpGaD
Masoprocol—CYP19A1—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.00126	0.00261	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—CDKN1B—glaucoma	0.00126	0.0026	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—MMP9—glaucoma	0.00125	0.00258	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.00121	0.00251	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—CAV1—glaucoma	0.00119	0.00247	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.00117	0.00242	CbGpPWpGaD
Masoprocol—CYP2J2—Biological oxidations—GSTM1—glaucoma	0.00116	0.00241	CbGpPWpGaD
Masoprocol—CYP2J2—Metapathway biotransformation—GSTM1—glaucoma	0.00115	0.00238	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CA5A—glaucoma	0.00114	0.00236	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—NARFL—glaucoma	0.00114	0.00236	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—FN1—glaucoma	0.00114	0.00235	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—BAD—glaucoma	0.00112	0.00233	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—LRP12—glaucoma	0.00111	0.00229	CbGpPWpGaD
Masoprocol—CYP19A1—Ovarian Infertility Genes—CDKN1B—glaucoma	0.0011	0.00227	CbGpPWpGaD
Masoprocol—IGF1R—MicroRNAs in cardiomyocyte hypertrophy—TNF—glaucoma	0.00107	0.00222	CbGpPWpGaD
Masoprocol—IGF1R—Apoptosis—TNF—glaucoma	0.00107	0.00222	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.00102	0.00211	CbGpPWpGaD
Masoprocol—ALOX5—Selenium Micronutrient Network—PTGS2—glaucoma	0.001	0.00207	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—TP53—glaucoma	0.000962	0.00199	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—TNF—glaucoma	0.00096	0.00199	CbGpPWpGaD
Masoprocol—IGF1R—Apoptosis—TP53—glaucoma	0.000944	0.00195	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—OPN4—glaucoma	0.000901	0.00187	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—EDN1—glaucoma	0.00089	0.00184	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—TP53—glaucoma	0.000846	0.00175	CbGpPWpGaD
Masoprocol—CYP19A1—Biological oxidations—GSTT1—glaucoma	0.000839	0.00174	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—HEYL—glaucoma	0.000838	0.00174	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PTGFR—glaucoma	0.000812	0.00168	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—TP53—glaucoma	0.00079	0.00164	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—C3—glaucoma	0.000778	0.00161	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—OPN4—glaucoma	0.000766	0.00159	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—HEYL—glaucoma	0.000713	0.00148	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—SMO—glaucoma	0.000693	0.00143	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PTGFR—glaucoma	0.00069	0.00143	CbGpPWpGaD
Masoprocol—ALOX5—Selenium Micronutrient Network—TNF—glaucoma	0.000675	0.0014	CbGpPWpGaD
Masoprocol—CYP19A1—Biological oxidations—CYP1B1—glaucoma	0.000669	0.00138	CbGpPWpGaD
Masoprocol—CYP19A1—Metapathway biotransformation—CYP1B1—glaucoma	0.000659	0.00137	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—VEGFA—glaucoma	0.00065	0.00135	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—RPTOR—glaucoma	0.000635	0.00132	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CA1—glaucoma	0.000625	0.0013	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000625	0.00129	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NCK2—glaucoma	0.000615	0.00127	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CTSA—glaucoma	0.000606	0.00125	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—NARFL—glaucoma	0.000588	0.00122	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CA5A—glaucoma	0.000588	0.00122	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CA2—glaucoma	0.000572	0.00118	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000559	0.00116	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000559	0.00116	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CA1—glaucoma	0.000557	0.00115	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—RPTOR—glaucoma	0.00054	0.00112	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CTSA—glaucoma	0.00054	0.00112	CbGpPWpGaD
Masoprocol—CYP19A1—Biological oxidations—GSTM1—glaucoma	0.000534	0.00111	CbGpPWpGaD
Masoprocol—CYP19A1—Metapathway biotransformation—GSTM1—glaucoma	0.000527	0.00109	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NCK2—glaucoma	0.000523	0.00108	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—HDAC9—glaucoma	0.000523	0.00108	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CA2—glaucoma	0.00051	0.00106	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—MMP1—glaucoma	0.000504	0.00104	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—EDN1—glaucoma	0.000503	0.00104	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000498	0.00103	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000498	0.00103	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—EDN1—glaucoma	0.000457	0.000946	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—BAD—glaucoma	0.000455	0.000942	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—HDAC9—glaucoma	0.000445	0.000921	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—C3—glaucoma	0.000439	0.00091	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—SMO—glaucoma	0.000409	0.000847	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—TXN—glaucoma	0.000403	0.000835	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—C3—glaucoma	0.000399	0.000826	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NTRK2—glaucoma	0.000374	0.000775	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.000368	0.000762	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	0.000364	0.000755	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—TXN—glaucoma	0.000359	0.000744	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—SMO—glaucoma	0.000348	0.000721	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.000328	0.000679	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—CAV1—glaucoma	0.000325	0.000673	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NGFR—glaucoma	0.000321	0.000665	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NTRK2—glaucoma	0.000318	0.000659	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—GSTT1—glaucoma	0.000313	0.000647	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NTRK1—glaucoma	0.000305	0.000632	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CA1—glaucoma	0.000287	0.000595	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CDKN2B—glaucoma	0.000281	0.000582	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GSTT1—glaucoma	0.000279	0.000577	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CTSA—glaucoma	0.000278	0.000576	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NGFR—glaucoma	0.000273	0.000565	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—EDN1—glaucoma	0.00027	0.000559	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—glaucoma	0.000263	0.000545	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CA2—glaucoma	0.000263	0.000544	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NTRK1—glaucoma	0.000259	0.000537	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000257	0.000532	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000257	0.000532	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	0.000252	0.000522	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ABCA1—glaucoma	0.000249	0.000516	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CYP1B1—glaucoma	0.000249	0.000516	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NGF—glaucoma	0.000248	0.000513	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CDKN2B—glaucoma	0.000239	0.000495	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—C3—glaucoma	0.000236	0.000488	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—EDN1—glaucoma	0.000229	0.000475	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	0.000225	0.000465	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CYP1B1—glaucoma	0.000222	0.00046	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ABCA1—glaucoma	0.000222	0.00046	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—APOE—glaucoma	0.000219	0.000454	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CAV1—glaucoma	0.000217	0.00045	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NGF—glaucoma	0.000211	0.000437	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—FN1—glaucoma	0.000207	0.000429	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—BAD—glaucoma	0.000204	0.000423	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—C3—glaucoma	0.0002	0.000415	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—GSTM1—glaucoma	0.000199	0.000412	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—TP53—glaucoma	0.000199	0.000412	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—APOE—glaucoma	0.000187	0.000386	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—TXN—glaucoma	0.000185	0.000383	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CAV1—glaucoma	0.000185	0.000383	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GSTM1—glaucoma	0.000177	0.000367	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—FN1—glaucoma	0.000176	0.000364	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—MTHFR—glaucoma	0.000176	0.000364	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—BAD—glaucoma	0.000174	0.00036	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.000169	0.00035	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	0.000167	0.000346	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NOS3—glaucoma	0.000164	0.00034	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—APOE—glaucoma	0.000164	0.000339	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CAV1—glaucoma	0.000162	0.000336	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—MTHFR—glaucoma	0.000157	0.000325	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—APOE—glaucoma	0.000146	0.000302	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CAV1—glaucoma	0.000145	0.000299	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GSTT1—glaucoma	0.000143	0.000297	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CDKN1B—glaucoma	0.000142	0.000295	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NOS3—glaucoma	0.00014	0.000289	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MMP9—glaucoma	0.000132	0.000273	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—NOS3—glaucoma	0.000123	0.000254	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CDKN1B—glaucoma	0.000121	0.000251	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—VEGFA—glaucoma	0.000118	0.000245	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	0.000116	0.00024	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ABCA1—glaucoma	0.000114	0.000237	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CYP1B1—glaucoma	0.000114	0.000237	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PTGS2—glaucoma	0.000112	0.000232	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MMP9—glaucoma	0.000112	0.000232	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—NOS3—glaucoma	0.000109	0.000226	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—VEGFA—glaucoma	0.000101	0.000209	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PTGS2—glaucoma	0.0001	0.000207	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GSTM1—glaucoma	9.14e-05	0.000189	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—TP53—glaucoma	8.95e-05	0.000185	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—MTHFR—glaucoma	8.08e-05	0.000167	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—TP53—glaucoma	7.61e-05	0.000158	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—APOE—glaucoma	7.52e-05	0.000156	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CAV1—glaucoma	7.45e-05	0.000154	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—NOS3—glaucoma	5.63e-05	0.000117	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PTGS2—glaucoma	5.15e-05	0.000107	CbGpPWpGaD
